Annovis Bio, Inc. (ANVS)

Annovis Bio Statistics

Total Valuation

Annovis Bio has a market cap or net worth of $50.10 million. The enterprise value is $32.97 million.

Market Cap	50.10M
Enterprise Value	32.97M

Important Dates

The next estimated earnings date is Wednesday, November 12, 2025, before market open.

Earnings Date	Nov 12, 2025
Ex-Dividend Date	n/a

Share Statistics

Annovis Bio has 23.30 million shares outstanding. The number of shares has increased by 55.91% in one year.

Current Share Class	23.30M
Shares Outstanding	23.30M
Shares Change (YoY)	+55.91%
Shares Change (QoQ)	+11.79%
Owned by Insiders (%)	12.42%
Owned by Institutions (%)	12.06%
Float	20.41M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	n/a
Forward PS	n/a
PB Ratio	2.29
P/TBV Ratio	2.73
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 7.65

Current Ratio	7.65
Quick Ratio	6.11
Debt / Equity	n/a
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	n/a

Financial Efficiency

Return on equity (ROE) is -365.03% and return on invested capital (ROIC) is -178.51%.

Return on Equity (ROE)	-365.03%
Return on Assets (ROA)	-111.68%
Return on Invested Capital (ROIC)	-178.51%
Return on Capital Employed (ROCE)	-126.96%
Revenue Per Employee	n/a
Profits Per Employee	-$2.02M
Employee Count	15
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -78.22% in the last 52 weeks. The beta is 1.63, so Annovis Bio's price volatility has been higher than the market average.

Beta (5Y)	1.63
52-Week Price Change	-78.22%
50-Day Moving Average	2.22
200-Day Moving Average	2.39
Relative Strength Index (RSI)	52.31
Average Volume (20 Days)	1,403,084

Short Selling Information

The latest short interest is 1.30 million, so 5.57% of the outstanding shares have been sold short.

Short Interest	1.30M
Short Previous Month	1.59M
Short % of Shares Out	5.57%
Short % of Float	6.36%
Short Ratio (days to cover)	1.28

Income Statement

Revenue	n/a
Gross Profit	n/a
Operating Income	-23.68M
Pretax Income	-30.26M
Net Income	-30.26M
EBITDA	n/a
EBIT	-23.68M
Earnings Per Share (EPS)	-$1.90

Balance Sheet

The company has $17.13 million in cash and n/a in debt, giving a net cash position of $17.13 million or $0.74 per share.

Cash & Cash Equivalents	17.13M
Total Debt	n/a
Net Cash	17.13M
Net Cash Per Share	$0.74
Equity (Book Value)	18.33M
Book Value Per Share	0.94
Working Capital	18.65M

Cash Flow

Operating Cash Flow	-24.69M
Capital Expenditures	n/a
Free Cash Flow	n/a
FCF Per Share	n/a

Margins

Gross Margin	n/a
Operating Margin	n/a
Pretax Margin	n/a
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

Annovis Bio does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-55.91%
Shareholder Yield	-55.91%
Earnings Yield	-60.40%
FCF Yield	n/a

Analyst Forecast

The average price target for Annovis Bio is $17.33, which is 706.05% higher than the current price. The consensus rating is "Strong Buy".

Price Target	$17.33
Price Target Difference	706.05%
Analyst Consensus	Strong Buy
Analyst Count	4
Revenue Growth Forecast (5Y)	n/a
EPS Growth Forecast (5Y)	-29.63%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Altman Z-Score	n/a
Piotroski F-Score	2